Cyclohexane-1,1,2-triol | 30141-64-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Cyclohexane-1,1,2-triol
• CAS: 30141-64-1
• 化学式: C₆H₁₂O₃
• 分子量: 132.16
• InChiKey: FNTHQRXVZDCWSP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  60.7
• 氢给体数：
  3
• 氢受体数：
  3

文献信息

• [EN] MODULAR SYNTHESIS OF AMINOGLYCOSIDES<br/>[FR] SYNTHÈSE MODULAIRE D'AMINOGLYCOSIDES
  申请人：ACHAOGEN INC

  公开号：WO2019194858A1

  公开（公告）日：2019-10-10

  The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds and the compounds used in such preparations.

  本公开涉及制备抗菌氨基糖苷化合物的新方法以及用于这种制备中的化合物。
• Aromatics conversion with ITQ-13
  申请人：——

  公开号：US20040087822A1

  公开（公告）日：2004-05-06

  There is provided a process for aromatics conversion by contacting a feed suitable for aromatics conversion under conversion condition and in the presence of a catalyst comprising ITQ-13. Examples of such conversion processes include isomerization of aromatic (xylenes) feedstock, disproportionation of toluene to benzene and xylenes, alkylation and transalkylation of aromatics, conversion of light paraffins and light olefins to aromatics, conversion of naphtha to aromatics, and conversion of alcohol to aromatics.

  提供了一种芳烃转化的过程，通过在转化条件下并在存在包含ITQ-13的催化剂的情况下接触适合芳烃转化的原料。这种转化过程的示例包括芳烃（二甲苯）原料的异构化、甲苯的不成比例反应生成苯和二甲苯、芳烃的烷基化和烷基交换、将轻质烷烃和轻质烯烃转化为芳烃、将石脑油转化为芳烃，以及将醇转化为芳烃。
• Internal release agent, composition including internal release agent, and process for producing a plastic lens using same composition
  申请人：MITSUI CHEMICALS, INC.

  公开号：US10239239B2

  公开（公告）日：2019-03-26

  An internal release agent includes at least one phosphodiester represented by the following general formula (1). In the formula, R1 and R2 independently represent a hydrocarbon group having 1 to 30 carbon atoms, which is optionally substituted with at least one hydroxyl group, and R3 represents an alkylene group having 2 to 4 carbon atoms. A plurality of R3's may be the same as or different from each other. M represents a hydrogen atom, an ammonium ion, an alkali metal ion, or a monovalent/divalent alkali earth metal ion, and n is an integer of 1 to 60.

  内部释放剂至少包括一个由以下一般式（1）表示的磷酸二酯。在该式中，R1和R2分别表示具有1至30个碳原子的烃基，该烃基可以选择性地取代至少一个羟基，而R3表示具有2至4个碳原子的烷基基团。多个R3可以相同或者彼此不同。M代表氢原子、铵离子、碱金属离子或者一价/二价碱土金属离子，n为1至60的整数。
• PROCESS FOR PRODUCING PENTAERYTHRITOL MERCAPTOCARBOXYLIC ACID ESTER, POLYMERIZABLE COMPOSITION, RESIN, OPTICAL MATERIAL, AND LENS
  申请人：MITSUI CHEMICALS, INC.

  公开号：US20180186733A1

  公开（公告）日：2018-07-05

  A process for producing a pentaerythritol mercaptocarboxylic acid ester of the present invention includes: a step of reacting pentaerythritol with a mercaptocarboxylic acid, in which an absorbance of a 5 wt % aqueous solution of the pentaerythritol at a wavelength of 270 nm, which is measured using a quartz cell having an optical path length of 50 mm, is 0.07 or less.

  本发明的一种生产对羟基羧基巯基脂肪酸酯的工艺包括：将对羟基羧基巯基脂肪酸与对羟基羧基醇反应的步骤，其中在使用光路长度为50毫米的石英池测量的270纳米波长处，对5重量%的对羟基羧基醇水溶液的吸光度为0.07或更低。
• Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
  申请人：——

  公开号：US20040122069A1

  公开（公告）日：2004-06-24

  Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, 1 in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.

  披露了二芳基环烷基衍生物及其生理上可接受的盐和生理功能衍生物。这些化合物包括式I,1中定义的基团，以及它们的生理上可接受的盐和制备方法。这些化合物通常具有降脂和/或三酸甘油酯降低作用，并且适用于例如治疗脂质代谢紊乱、II型糖尿病和X综合征等疾病。